Cytokines and other soluble factors in dialysate -: Indicators of altered peritoneal function?

被引:5
作者
Martikainen, TA [1 ]
Ekstrand, AV [1 ]
Teppo, AM [1 ]
Honkanen, EO [1 ]
Grönhagen-Riska, C [1 ]
机构
[1] Univ Helsinki, Cent Hosp, Dept Med, Div Nephrol, FI-00029 Helsinki, Finland
来源
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY | 2002年 / 36卷 / 06期
关键词
cytokines; dialysis adequacy; growth factors; peritoneal membrane; soluble factors in dialysate; ultrafiltration failure;
D O I
10.1080/003655902762467620
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: The bioincompatibility of dialysis Solutions and recurrent episodes of peritonitis may alter peritoneal function. Cytokines and growth factors may play a role in inflammatory and fibrotic processes. We therefore investigated whether there is a correlation between peritoneal function and excretion of cytokines and other soluble factors in dialysate. Material and Methods: A personal dialysis capacity test was performed in 40 stable peritoneal dialysis patients. Tumour necrosis factor-alpha, interleukin-6 (IL-6), hyaluronan, soluble intercellular cell adhesion molecule-1 and transforming growth factor-beta1 were analysed from overnight and 24-h dialysates during the test. Results: We found little evidence for a direct correlation between cytokines and other soluble factors in dialysate and dialysis adequacy. There was. however. a strong correlation between the measured soluble factors and characteristics of the peritoneal membrane. Furthermore, IL-6 correlated with the number of previous episodes of peritonitis. Conclusions: Soluble factors in dialysate may indicate ongoing inflammatory processes in the peritoneal membrane, which may gradually lead to alterations in peritoneal function.
引用
收藏
页码:450 / 454
页数:5
相关论文
共 21 条
[1]   Human peritoneal fibroblast proliferation in 3-dimensional culture: Modulation by cytokines, growth factors and peritoneal dialysis effluent [J].
Beavis, MJ ;
Williams, JD ;
Hoppe, J ;
Topley, N .
KIDNEY INTERNATIONAL, 1997, 51 (01) :205-215
[2]  
Breborowicz A, 1998, PERITON DIALYSIS INT, V18, P382
[3]  
Davies SJ, 1996, NEPHROL DIAL TRANSPL, V11, P498
[4]  
DOBBIE JW, 1992, PERITON DIALYSIS INT, V12, P14
[5]  
GALLARD R, 1994, CYTOKINE FACTS BOOK, P64
[6]   ASSESSING THE PERITONEAL-DIALYSIS CAPACITIES OF INDIVIDUAL PATIENTS [J].
HARALDSSON, B .
KIDNEY INTERNATIONAL, 1995, 47 (04) :1187-1198
[7]   HYALURONAN [J].
LAURENT, TC ;
FRASER, JRE .
FASEB JOURNAL, 1992, 6 (07) :2397-2404
[8]  
Lin CY, 1997, ADV PERIT D, V13, P64
[9]   Words of wisdom [J].
Mateosian, R .
IEEE MICRO, 1999, 19 (02) :5-+
[10]  
ROTHLEIN R, 1991, J IMMUNOL, V147, P3588